Skip to content

Clinical trials

Completed Schizophrenia trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Brazil Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20043
20051
20068
20071
20085
20104
20113
20123
20144
20152
20171
20191
20214
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
Hoffmann-La Roche4
Boehringer Ingelheim3
Federal University of São Paulo3
Hospital de Clinicas de Porto Alegre3
Janssen Research & Development, LLC3
University of Sao Paulo3
FORUM Pharmaceuticals Inc2
Janssen-Cilag Farmaceutica Ltda.2
Janssen-Cilag Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia46
Psychotic Disorders10
Cognition Disorders2
Hallucinations2
Bipolar Disorder1
Body Weight Changes1
Depressive Disorder1
Mania1
Obesity1
Schizophrenia Spectrum and Other Psychotic Disorders1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.